Alembic Pharma plans Rs 720-crore capex for FY19

The pharma firm has filed 12 ANDAs (abbreviated new drug applications) during the March quarter, taking the total filings in FY18 to 26.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news